These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 7715467)

  • 1. The role of prolactin in the menopause.
    Metka M; Holzer G; Raimann H; Heytmanek G; Hartmann B; Kurz C
    Maturitas; 1994 Dec; 20(2-3):151-4. PubMed ID: 7715467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonism of oestrogen-induced prolactin release by medroxyprogesterone acetate.
    Castelo-Branco C; Palacios S; Martinez de Osaba MJ; Balasch J; Fortuny A; Vanrell J
    Maturitas; 1994 Dec; 20(2-3):145-50. PubMed ID: 7715466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation between plasma hormone profiles, symptoms, and response to oestrogen treatment in women approaching the menopause.
    Chakravarti S; Collins WP; Thom MH; Studd JW
    Br Med J; 1979 Apr; 1(6169):983-5. PubMed ID: 219937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oestrogens and menopausal and postmenopausal women.
    Hailes J; Burger H
    Med J Aust; 1977 May; 1(22):803-6. PubMed ID: 196165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactin levels in menopausal women on long-term estrogen implants.
    Goh HH; McCarthy TG; Dramusic V; Ratnam SS
    Gynecol Endocrinol; 1989 Jun; 3(2):153-7. PubMed ID: 2510462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrinological features and endometrial morphology in climacteric women receiving hormone replacement therapy.
    Grasso A; Baraghini F; Barbieri C; Dalla Vecchia E; Previdi AM; Di Renzo GC; Volpe A
    Maturitas; 1982 Apr; 4(1):19-26. PubMed ID: 6285153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Climacteric symptoms, fat mass, and plasma concentrations of LH, FSH, Prl, oestradiol-17 beta and androstenedione in the early post-menopausal period.
    Hagen C; Christiansen C; Christensen MS; Transbøl I
    Acta Endocrinol (Copenh); 1982 Sep; 101(1):87-92. PubMed ID: 6812347
    [No Abstract]   [Full Text] [Related]  

  • 8. Bioidentical hormone replacement therapy. Customizing care for perimenopausal and menopausal women.
    Romero M
    Adv Nurse Pract; 2002 Nov; 10(11):47-8, 51-2. PubMed ID: 12478948
    [No Abstract]   [Full Text] [Related]  

  • 9. Psycho-endocrine differences and correlations in symptomatic and asymptomatic climacteric women - the possible role of prolactin.
    Sonnendecker EW; Polakow ES; Gerdes L
    S Afr Med J; 1981 Oct; 60(17):661-5. PubMed ID: 6272429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
    Reyes FI; Winter JS; Faiman C
    Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of conjugated equine oestrogens with and without the addition of cyclical medrogestone on hot flushes, liver function, blood pressure and endocrinological indices.
    Sonnendecker EW; Polakow ES
    S Afr Med J; 1990 Mar; 77(6):281-5. PubMed ID: 2156343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of estradiol valerate plus medroxyprogesterone acetate and conjugated estrogens plus medrogestone on climacteric symptoms and metabolic variables in perimenopausal women.
    Egarter C; Geurts P; Boschitsch E; Speiser P; Huber J
    Acta Obstet Gynecol Scand; 1996 Apr; 75(4):386-93. PubMed ID: 8638462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of low dose oestrogen on circulating prolactin. LH and FSH levels in post-menopausal women.
    Robyn C; Vekemans M
    Acta Endocrinol (Copenh); 1976 Sep; 83(1):9-14. PubMed ID: 989226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of aging and gonadal failure on the hypothalamic-pituitary axis in women.
    Santoro N; Banwell T; Tortoriello D; Lieman H; Adel T; Skurnick J
    Am J Obstet Gynecol; 1998 Apr; 178(4):732-41. PubMed ID: 9579435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of climacteric and postmenopausal women with 17-beta-oestradiol and norethisterone acetate.
    Furuhjelm M; Carlström K
    Acta Obstet Gynecol Scand; 1977; 56(4):351-61. PubMed ID: 602703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of hormone replacement therapy on growth hormone secretion patterns in correlation to somatometric parameters in healthy postmenopausal women.
    Hartmann B; Kirchengast S; Albrecht A; Laml T; Bikas D; Huber J
    Maturitas; 1995 Nov; 22(3):239-46. PubMed ID: 8746882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Blood levels of estradiol, FSH and LH in women with climacteric syndrome--conjugated estrogen therapy].
    Kano T; Nishikawa K
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Feb; 36(2):189-94. PubMed ID: 6421967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Eye manifestations as climacteric symptom].
    Metka M; Enzelsberger H; Knogler W; Schurz B; Aichmair H
    Geburtshilfe Frauenheilkd; 1991 Feb; 51(2):143-5. PubMed ID: 1645692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in prolactin levels with the menopause: the effects of estrogen/androgen and calcitonin treatment.
    Balint-Perić LA; Prelević GM
    Gynecol Endocrinol; 1997 Aug; 11(4):275-80. PubMed ID: 9272425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect and tolerability of sequential administration of estradiol valerate and medroxyprogesterone acetate on menopausal symptoms, hormonal profile and biochemical markers in climacteric women].
    Radowicki S; Skórzewska K; Borakowska B; Wierzba W; Michalewski K
    Ginekol Pol; 2004 Jan; 75(1):39-46. PubMed ID: 15112472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.